T(11;14) POSITIVE

Clinical trials for T(11;14) POSITIVE explained in plain language.

Never miss a new study

Get alerted when new T(11;14) POSITIVE trials appear

Sign up with your email to follow new studies for T(11;14) POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare blood disorder: trial tests targeted combo therapy

Disease control Not yet recruiting

This study is testing a new combination of drugs for adults with a rare and serious blood disorder called AL amyloidosis, specifically those with a genetic marker called t(11;14). The goal is to see if adding a new drug called sonrotoclax to standard treatments can better control…

Matched conditions: T(11;14) POSITIVE

Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

T(11;14) POSITIVE

Get alerted when new T(11;14) POSITIVE trials appear

New hope for rare blood disorder: trial tests targeted combo therapy